Our new WHISTL facility enables us to run medical devices through tougher, more realistic test regimes. Hidden vulnerabilities surface faster, and we can keep the focus on patient safety. – Ben Esslinger, CBET Manager & Clinical Engineer, Eskenazi Health
San Francisco, CA (PRWEB)
July 27, 2017
MDISS, the Medical Device Innovation, Safety and Security Consortium today launched the first of more than a dozen planned device security testing labs and cyber-ranges. The new MDISS World Health Information Security Testing Lab (WHISTL) facilities will comprise a federated network of medical device security testing labs, independently owned and operated by MDISS-member organizations including healthcare delivery organizations, medical device manufacturers, universities and technology companies. Each WHISTL facility will launch and operate under a shared set of standard operating procedures. The goal is to help organizations work together to more effectively address the public health challenges arising from cybersecurity issues emergent in complex, multi-vendor networks of medical devices.
While such security ‘proving grounds’ aren’t new to enterprise IT, WHISTL is the first network of labs specifically designed around the needs of medical device researchers, healthcare IT professionals and hospital clinical engineering leaders. By the end of 2017, MDISS WHISTL facilities will open in New York, Indiana, Tennessee, California as well as in the UK, Israel, Finland and Singapore.
Benjamin G. Esslinger, CBET Manager/Clinical Engineer at Eskenazi Health, said “Working with…